Phillip A. Sharp - Feb 9, 2022 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Phillip A. Sharp
Stock symbol
ALNY
Transactions as of
Feb 9, 2022
Transactions value $
-$4,160,100
Form type
4
Date filed
2/11/2022, 03:04 PM
Previous filing
Jul 19, 2021
Next filing
May 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $340K +30K $11.33* 30K Feb 9, 2022 Direct F1
transaction ALNY Common Stock Sale -$4.5M -30K -100% $150.00 0 Feb 9, 2022 Direct F1
holding ALNY Common Stock 267K Feb 9, 2022 by Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Options Exercise $0 -30K -100% $0.00* 0 Feb 9, 2022 Common Stock 30K $11.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2021. The 30,000 options exercised and sold by the reporting person were due to expire on June 21, 2022.
F2 Includes shares held by the Phillip A. Sharp Revocable Trust, of which the reporting person and his spouse are co-trustees. Also includes shares held in trust for the benefit of the reporting persons children, of which the reporting persons children and spouse are the trustees.